We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes.
- Authors
Rosen, Allison B; Karter, Andrew J; Liu, Jennifer Y; Selby, Joe V; Schneider, Eric C
- Abstract
Diabetes causes 45% of incident end-stage renal disease (ESRD). Risk of progression is higher in those with clinical risk factors (albuminuria and hypertension), and in ethnic minorities (including blacks, Asians, and Latinos). Angiotensin-converting enzyme inhibitors (ACE) and angiotensin receptor blockers (ARB) slow the progression of diabetic nephropathy, yet little is known about their use among patients at high risk for progression to ESRD.
- Publication
Journal of general internal medicine, 2004, Vol 19, Issue 6, p669
- ISSN
0884-8734
- Publication type
Journal Article
- DOI
10.1111/j.1525-1497.2004.30264.x